Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: J Diabetes Complications. 2017 Feb 21;31(5):869–873. doi: 10.1016/j.jdiacomp.2017.02.009

Figure. Annual SH rates* among patients with diabetes treated with insulin or a secretagogue (Sulfonylureas or Meglitinides) in the SUPREME-DM DataLink. (2005–2011).

Figure

*Age & sex standardized to the 2010 U.S. population; solid lines for race-specific trends, dashed line for total population trend